Related references
Note: Only part of the references are listed.Attenuation of Renoinflammatory Cascade in Experimental Model of Diabetic Nephropathy by Sesamol
Anurag Kuhad et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy
Kathryn M. Thrailkill et al.
ENDOCRINE (2009)
Experimental models for nephropathy
Pitchai Balakumar et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2008)
The pathogenesis of diabetic nephropathy
Suma Dronavalli et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats
Atsushi Gojo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Rodent models of streptozotocin-induced diabetic nephropathy
Greg H. Tesch et al.
NEPHROLOGY (2007)
C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats
B Samnegard et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats
T Yokozawa et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Effect of chronic treatment with losartan on streptozotocin-induced renal dysfunction
B Murali et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats
N Aksoy et al.
CELL BIOCHEMISTRY AND FUNCTION (2003)
Progression of diabetic nephropathy
R Kikkawa et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes
JL Evans et al.
ENDOCRINE REVIEWS (2002)
Animal model of diabetic nephropathy
T Yokozawa et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2001)